An Open Label, Phase II Trial of Pre-operative Neratinib and Endocrine Therapy with Trastuzumab in ER-Positive, HER2-Positive Breast Cancers

Status: Open to Accrual

Learn more:

• https://clinicaltrials.gov/study/NCT04886531

Study Contact: studies@hoosiercancer.org; (317) 921-2050.